Definitive salvage radiation therapy and chemoradiation therapy for lymph node oligo-recurrence of esophageal cancer: a Japanese multi-institutional study of 237 patients

af Yamashita, Hideomi, Jingu, Keiichi, Niibe, Yuzuru, Katsui, Kuniaki, Matsumoto, Toshihiko, Nishina, Tomohiro, Terahara, Atsuro
Udgivet i Radiat Oncol (2017)

Re-irradiation for oligo-recurrence from esophageal cancer with radiotherapy history: a multi-institutional study

af Jingu, Keiichi, Niibe, Yuzuru, Yamashita, Hideomi, Katsui, Kuniaki, Matsumoto, Toshihiko, Nishina, Tomohiro, Terahara, Atsuro
Udgivet i Radiat Oncol (2017)

Pertuzumab plus trastuzumab and chemotherapy for Japanese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer: a subgroup analysis of the JACOB trial

af Shitara, Kohei, Hara, Hiroki, Yoshikawa, Takaki, Fujitani, Kazumasa, Nishina, Tomohiro, Hosokawa, Ayumu, Asakawa, Takashi, Kawakami, Satoe, Muro, Kei
Udgivet i Int J Clin Oncol (2019)

Phase II trial of nanoparticle albumin-bound paclitaxel as second-line chemotherapy for unresectable or recurrent gastric cancer

af Sasaki, Yasutsuna, Nishina, Tomohiro, Yasui, Hirofumi, Goto, Masahiro, Muro, Kei, Tsuji, Akihito, Koizumi, Wasaburo, Toh, Yasushi, Hara, Takuo, Miyata, Yoshinori
Udgivet i Cancer Sci (2014)

Maximum standardized uptake value in (18)F-fluoro-2-deoxyglucose positron emission tomography is associated with advanced tumor factors in esophageal cancer

af KAJIWARA, TAKESHI, HIASA, YOICHI, NISHINA, TOMOHIRO, MATSUMOTO, TOSHIHIKO, HORI, SHINICHIRO, NADANO, SEIJIN, IGUCHI, HARUO, TAKEJI, SATORU, TSUBOUCHI, EIJI, IKEDA, YOSHIO, ONJI, MORIKAZU
Udgivet 2014

Multicenter Retrospective Study of 132 Patients with Unresectable Small Bowel Adenocarcinoma Treated with Chemotherapy

af Tsushima, Takahiro, Taguri, Masataka, Honma, Yoshitaka, Takahashi, Hideaki, Ueda, Shinya, Nishina, Tomohiro, Kawai, Hiroki, Kato, Shunsuke, Suenaga, Mitsukuni, Tamura, Fumio, Morita, Satoshi, Boku, Narikazu
Udgivet 2012

A Phase II Clinical Study of mFOLFOX6 Plus Bevacizumab as First-line Therapy for Japanese Advanced/Recurrent Colorectal Cancer Patients

af Nishina, Tomohiro, Takano, Yoshinao, Denda, Tadamichi, Yasui, Hisateru, Takeda, Koji, Ura, Takashi, Esaki, Taito, Okuyama, Yusuke, Kondo, Ken, Takahashi, Yasuo, Sugiyama, Yasuyuki, Muro, Kei
Udgivet 2013

Simultaneous identification of 36 mutations in KRAS codons 61and 146, BRAF, NRAS, and PIK3CA in a single reaction by multiplex assay kit

af Bando, Hideaki, Yoshino, Takayuki, Shinozaki, Eiji, Nishina, Tomohiro, Yamazaki, Kentaro, Yamaguchi, Kensei, Yuki, Satoshi, Kajiura, Shinya, Fujii, Satoshi, Yamanaka, Takeharu, Tsuchihara, Katsuya, Ohtsu, Atsushi
Udgivet 2013

A Phase I/II Study of XELIRI Plus Bevacizumab as Second-Line Chemotherapy for Japanese Patients With Metastatic Colorectal Cancer (BIX Study)

af Hamamoto, Yasuo, Yamaguchi, Tatsuro, Nishina, Tomohiro, Yamazaki, Kentaro, Ura, Takashi, Nakajima, Takako, Goto, Ayumu, Shimada, Ken, Nakayama, Norisuke, Sakamoto, Junichi, Morita, Satoshi, Yamada, Yasuhide
Udgivet i Oncologist (2014)

Multicenter phase II study of FOLFIRI plus bevacizumab after discontinuation of oxaliplatin-based regimen for advanced or recurrent colorectal cancer (CR0802)

af Suenaga, Mitsukuni, Nishina, Tomohiro, Mizunuma, Nobuyuki, Yasui, Hisateru, Ura, Takashi, Denda, Tadamichi, Ikeda, Junichi, Esaki, Taito, Nishisaki, Hogara, Takano, Yoshinao, Sugiyama, Yasuyuki, Muro, Kei
Udgivet i BMC Cancer (2015)

Multicenter retrospective analysis of systemic chemotherapy for advanced neuroendocrine carcinoma of the digestive system

af Yamaguchi, Tomohiro, Machida, Nozomu, Morizane, Chigusa, Kasuga, Akiyoshi, Takahashi, Hideaki, Sudo, Kentaro, Nishina, Tomohiro, Tobimatsu, Kazutoshi, Ishido, Kenji, Furuse, Junji, Boku, Narikazu, Okusaka, Takuji
Udgivet i Cancer Sci (2014)

Clinical Validation of a Multiplex Kit for RAS Mutations in Colorectal Cancer: Results of the RASKET (RAS KEy Testing) Prospective, Multicenter Study

af Yoshino, Takayuki, Muro, Kei, Yamaguchi, Kensei, Nishina, Tomohiro, Denda, Tadamichi, Kudo, Toshihiro, Okamoto, Wataru, Taniguchi, Hiroya, Akagi, Kiwamu, Kajiwara, Takeshi, Hironaka, Shuichi, Satoh, Taroh
Udgivet i EBioMedicine (2015)

Protocol of a randomised phase III clinical trial of sequential capecitabine or 5-fluorouracil plus bevacizumab (Cape/5-FU-Bmab) to capecitabine or 5-fluorouracil plus oxaliplatin...

af Nagasaka, Takeshi, Mishima, Hideyuki, Sawaki, Akira, Shimokawa, Mototsugu, Inukai, Michio, Shinozaki, Katsunori, Tanioka, Hiroaki, Nasu, Junichiro, Nishina, Tomohiro, Hazama, Shoichi, Okajima, Masazumi, Yamaguchi, Yoshiyuki
Udgivet i BMJ Open (2016)

A multicentre, prospective study of plasma circulating tumour DNA test for detecting RAS mutation in patients with metastatic colorectal cancer

af Bando, Hideaki, Kagawa, Yoshinori, Kato, Takeshi, Akagi, Kiwamu, Denda, Tadamichi, Nishina, Tomohiro, Komatsu, Yoshito, Oki, Eiji, Kudo, Toshihiro, Kumamoto, Hiroshi, Yamanaka, Takeharu, Yoshino, Takayuki
Udgivet i Br J Cancer (2019)

Correction: A multicentre, prospective study of plasma circulating tumour DNA test for detecting RAS mutation in patients with metastatic colorectal cancer

af Bando, Hideaki, Kagawa, Yoshinori, Kato, Takeshi, Akagi, Kiwamu, Denda, Tadamichi, Nishina, Tomohiro, Komatsu, Yoshito, Oki, Eiji, Kudo, Toshihiro, Kumamoto, Hiroshi, Yamanaka, Takeharu, Yoshino, Takayuki
Udgivet i Br J Cancer (2020)

Phase 1 trial of avelumab (anti-PD-L1) in Japanese patients with advanced solid tumors, including dose expansion in patients with gastric or gastroesophageal junction cancer: the J...

af Doi, Toshihiko, Iwasa, Satoru, Muro, Kei, Satoh, Taroh, Hironaka, Shuichi, Esaki, Taito, Nishina, Tomohiro, Hara, Hiroki, Machida, Nozomu, Komatsu, Yoshito, Shimada, Yasuhiro, Otsu, Satoshi, Shimizu, Shin, Watanabe, Morihiro
Udgivet i Gastric Cancer (2018)

Quality of Life Associated with Ramucirumab Treatment in Patients with Advanced Gastric Cancer in Japan: Exploratory Analysis from the Phase III RAINBOW Trial

af Yamaguchi, Kensei, Shimada, Yasuhiro, Hironaka, Shuichi, Sugimoto, Naotoshi, Komatsu, Yoshito, Nishina, Tomohiro, Omuro, Yasushi, Tamura, Takao, Piao, Yongzhe, Homma, Gosuke, Jen, Min-Hua, Liepa, Astra M., Muro, Kei
Udgivet i Clin Drug Investig (2020)

First‐line sunitinib plus FOLFIRI in Japanese patients with unresectable/metastatic colorectal cancer: A phase II study

af Tsuji, Yasushi, Satoh, Taroh, Tsuji, Akihito, Muro, Kei, Yoshida, Motoki, Nishina, Tomohiro, Nagase, Michitaka, Komatsu, Yoshito, Kato, Takeshi, Miyata, Yoshinori, Mizutani, Naoko, Hashigaki, Satoshi, Lechuga, Maria Jose, Denda, Tadamichi
Udgivet i Cancer Sci (2012)

Determination of Prognostic Factors in Japanese Patients With Advanced Gastric Cancer Using the Data From a Randomized Controlled Trial, Japan Clinical Oncology Group 9912

af Takahari, Daisuke, Boku, Narikazu, Mizusawa, Junki, Takashima, Atsuo, Yamada, Yasuhide, Yoshino, Takayuki, Yamazaki, Kentaro, Koizumi, Wasaburo, Fukase, Kazutoshi, Yamaguchi, Kensei, Goto, Masahiro, Nishina, Tomohiro, Tamura, Takao, Tsuji, Akihito, Ohtsu, Atsushi
Udgivet 2014

Clinical Validation of Newly Developed Multiplex Kit Using Luminex xMAP Technology for Detecting Simultaneous RAS and BRAF Mutations in Colorectal Cancer: Results of the RASKET-B S...

af Taniguchi, Hiroya, Okamoto, Wataru, Muro, Kei, Akagi, Kiwamu, Hara, Hiroki, Nishina, Tomohiro, Kajiwara, Takeshi, Denda, Tadamichi, Hironaka, Shuichi, Kudo, Toshihiro, Satoh, Taroh, Yamanaka, Takeharu, Abe, Yukiko, Fukushima, Yoshiyuki, Yoshino, Takayuki
Udgivet i Neoplasia (2018)